Navigation Links
ICUROS study finds international variations in quality of life loss after fracture
Date:3/24/2011

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

The quality of life (QoL) of patients who sustained a hip, wrist or vertebral fracture was examined for the four months following the fracture. The study is part of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) which is an international patient-based study endorsed by the International Osteoporosis Foundation. ICUROS investigates the costs and health effects of osteoporotic fractures in women and men over the age of fifty. The aim is to gather better information regarding the burden of osteoporosis in the participating countries and worldwide. Currently, eleven countries are involved in ICUROS.

Involving 2,737 patients from nine countries, the study found that quality of life loss over four months was highest for hip fractures, followed by vertebral and wrist fractures. Interestingly, significant variations between countries were identified. Quality of life loss after hip fracture was greatest in Lithuania, followed by Italy, Russia and Mexico. Lower quality of life loss was experienced by hip fracture patients in Austria and Sweden. In all countries in which vertebral fractures were studied, patients who were hospitalized experienced more quality of life loss than those who were not hospitalized following vertebral fracture.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Children With Tourette Syndrome Have Better Motor Control, Study Finds
2. Americans Exposure to Mercury From Fish Wont Harm Hearts: Study
3. Even Mild Stress Can Lead to Disability, Study Says
4. Actos Cut Risk of Prediabetes Becoming Diabetes in Study
5. Menthol Cigarettes Pose No Added Lung Cancer Risk: Study
6. Mass. General study reveals how lung cancers evolve in response to targeted treatment
7. Sleep Less, Eat More: Study
8. Lung Cancer Evolves With Treatment, Study Finds
9. Long-term study: Robot-assisted prostate surgery is safe
10. Study: Infrequent Sex Can Raise Risk of Heart Attack, Death
11. UT MD Anderson receives grant for study of acupuncture in cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Mateo, CA (PRWEB) , ... April 28, 2017 , ... ... Area cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce ... allow interested persons to bookmark and read organized content on topics such as home ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... Malibu, CA (PRWEB) , ... April 27, 2017 , ... ... United States with an oil many times purer and more potent than the market ... mountain air of Gstaad, Switzerland, as well as a patented chromatography process for extraction, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... today released the podcast, “Make Plans for MACRA,” highlighting the impact ... the physician's office and how physicians and other clinicians are reimbursed for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: